Dr. Julia Linke (University of Mainz, Germany) joins AJP Audio to discuss the use of neural efficiency, a measure of brain activity, as a potential biomarker in the treatment of children with anxiety disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin joins the podcast to put the rest of the issue into context.

00:31 Linke interview
02:15 State or a trait?
04:15 Neural efficiency and CBT
05:22 Potential as a biomarker
07:08 Patient-rated and parent-rated measures of anxiety
08:16 Immediate clinical implications
09:50 Limitations
10:43 Future directions of research
11:44 Kalin interview
11:50 Linke et al.
15:16 Mallard et al.
18:11 Naples et al.
21:44 Mac Giollabhui et al.

Transcript

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org

January 2026: Reduced Threat-Related Neural Efficiency: A Possible Biomarker for Pediatric Anxiety Disorders